 |
|
Adult ImmunizationSummary of the National Vaccine Advisory Committee Report
David S. Fedson, MD;
the National Vaccine Advisory Committee;
Vincent A. Fulginiti, MD;
Barry R. Bloom, PhD;
Judy Braiman;
Betty F. Bumpers;
Robert B. Couch, MD;
R. Gordon Douglas, Jr, MD;
David S. Fedson, MD;
Charles M. Helms, MD, PhD;
Paul P. Hung, PhD;
Kay Johnson;
David T. Karzon, MD;
Susan M. Lett, MD, MPH;
Robert K. Ross, MD;
Daniel W. Shea, MD;
Sylvia F. Villarreal, MD
JAMA. 1994;272(14):1133-1137.
Abstract
| |
In January 1994 the National Vaccine Advisory Committee adopted a report that reviewed the status of adult immunization in the United States. Vaccine-preventable infections of adults represent a continuing cause of morbidity and mortality. Their major impact is among older persons. Effective and safe vaccines against these diseases are available, but they are poorly used. Several reasons account for low immunization levels among adults, including inadequate awareness by health care providers and the public of the importance and benefits of vaccination. Health care providers often fail to take advantage of opportunities to immunize adults during office, clinic, and hospital contacts and fail to organize programs in medical settings that ensure adults are offered the vaccines they need. Inadequate reimbursement for adult immunization by public and private health insurers and a lack of federal programs to support vaccine delivery are also major problems. The National Vaccine Advisory Committee's report includes five goals and 18 recommendations for improving adult immunization. To reach the Public Health Service adult immunization goals for the year 2000, the Committee recommends (1) improvements in public and provider education; (2) major changes in clinical practice; (3) increased financial support by public and private health insurers; (4) improved surveillance of vaccine-preventable diseases and vaccine production and delivery; and (5) support for research on vaccine-preventable diseases, new and improved vaccines, immunization practices, and international programs for adult immunization.
(JAMA. 1994;272:1133-1137)
Author Affiliations
University of Colorado Health Science Center, Denver; Albert Einstein College of Medicine, Bronx, NY; Empire State Consumer Association, Rochester, NY; Every Child By Two, Washington, DC; Baylor College of Medicine, Houston, Tex; Merck & Co Inc, Whitehouse Station, NJ; University of Virginia Medical Center, Charlottesville; University of Iowa, Iowa City; Wyeth-Ayerst Laboratories, Philadelphia, Pa; The March of Dimes, Washington, DC; Vanderbilt University School of Medicine, Nashville, Tenn; Massachusetts Department of Public Health, Jamaica Plain; Department of Health Services, San Diego, Calif; DePere, Wis; University of California-San Francisco
Footnotes
A complete list of committee members appears at the end of this article.
Reprint requests to National Vaccine Program Office, Rockwall II Bldg, Suite 1075, 5600 Fishers Ln, Rockville, MD 20852.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Improving Immunization Rates: Initial Results From a Team-Based, Systems Change Approach
Reynolds et al.
American Journal of Medical Quality 2008;23:176-183.
ABSTRACT
Influenza Vaccination Trends Among Adults 65 Years or Older in the United States, 1989-2002
Lu et al.
Arch Intern Med 2005;165:1849-1856.
ABSTRACT
| FULL TEXT
Failure to Vaccinate Medicare Inpatients: A Missed Opportunity
Bratzler et al.
Arch Intern Med 2002;162:2349-2356.
ABSTRACT
| FULL TEXT
Generalist and Subspecialist Physicians' Knowledge, Attitudes, and Practices Regarding Influenza and Pneumococcal Vaccinations for Elderly and Other High-Risk Patients: A Nationwide Survey
Nichol and Zimmerman
Arch Intern Med 2001;161:2702-2708.
ABSTRACT
| FULL TEXT
A Computerized Reminder System to Increase the Use of Preventive Care for Hospitalized Patients
Dexter et al.
NEJM 2001;345:965-970.
ABSTRACT
| FULL TEXT
Cost-effectiveness of Combined Outreach for the Pneumococcal and Influenza Vaccines
Weaver et al.
Arch Intern Med 2001;161:111-120.
ABSTRACT
| FULL TEXT
Prevention and Treatment of Influenza
Couch
NEJM 2000;343:1778-1787.
FULL TEXT
Revaccination of High-Risk Adults With Pneumococcal Polysaccharide Vaccine
Nichol
JAMA 1999;281:280-281.
FULL TEXT
Developing Curricula to Promote Preventive Medicine Skills: The Teaching Immunization for Medical Education (TIME) Project
Zimmerman et al.
JAMA 1997;278:705-711.
ABSTRACT
Immunization of Adolescents: Recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association
Committee on Infectious Diseases
Pediatrics 1997;99:479-488.
ABSTRACT
| FULL TEXT
Immunization of Adolescents: Recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association
JAMA 1997;277:202-207.
ABSTRACT
Side Effects Associated With Influenza Vaccination in Healthy Working Adults: A Randomized, Placebo-Controlled Trial
Nichol et al.
Arch Intern Med 1996;156:1546-1550.
ABSTRACT
Influenza and Pneumococcal Vaccination Coverage Levels Among Persons Aged >=65 Years-- United States, 1973-1993
JAMA 1995;274:530-531.
ABSTRACT
|
